In 2004-07 most Medicare-eligible men were getting radiation therapy for first-line treatment of prostate cancer

In a second article in the new journal JAMA Oncology, researchers at the University of California Los Angeles suggest that 58 percent of all relatively recent treatment for prostate cancer was being given by radiation therapy of some type, and that indolent prostate cancer was being significantly over-treated. … READ MORE …

Does use of PDE5 inhibitors post-treatment affect risk for biochemical recurrence?

A new article in the February 2015 of the Journal of Urology may actually tell us as much (or more) about the difficulties of relying on data from large, retrospective analyses of single institution data as it does about the actual issue references in the headline above. … READ MORE …

Some data from a randomized, prospective trial of surgery vs. radiation therapy

We should emphasize immediately that the available data from the trial discussed below are not exactly compelling. For whatever reasons, the trial didn’t enroll enough patients to allow any conclusions about the relative effectiveness to the two forms of treatment. … READ MORE …

Short-term outcomes after radical prostatectomy and surgeon training/practice site

Now here’s some data that may cause a bit of a furore … so before the US-based urologists get upset, we’d like to point out that this is a Canadian study based on data from members of the Canadian urology community in a single, unidentified Canadian province! … READ MORE …

Outcomes after intensive ADT and surgery in high-risk men with localized disease

The initial results of a small Phase II trial of androgen deprivation therapy (ADT) + abiraterone acetate prior to surgery in high-risk patients have now been published. … READ MORE …

Should we debulk the primary tumor in some men with metastatic prostate cancer?

Back in the 1980s, it would never (well, probably nearly never) have crossed anyone’s mind to carry out any type of primary tumor-debulking treatment on any patient who was newly diagnosed with evident, metastatic prostate cancer. … READ MORE …

Risk for conversion from minimally invasive to open surgery for prostate cancer patients

A new paper in the Journal of Urology provides us with a detailed assessment of the likelihood of and the risks associated with the need to convert from a minimally invasive (e.g., robot-assisted) to an open surgical procedure during the course of a radical prostatectomy. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,245 other followers